Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ATOPAXAR
(2)
Small molecule
Proteinase-activated receptor 1 antagonist
Unknown
Investigational
Unknown
ATOPAXAR
×
Maximum Phase:
2
First Approval:
None
UNII:
HTI275SD2D
Molecule Type:
Small molecule
Molecular Formula:
C29H38FN3O5
Molecular Weight:
527.64
AlogP:
4.79
PSA:
84.32
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PERPHENAZINE 4-AMINOBUTYRATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PERPHENAZINE 4-AMINOBUTYRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
K1WO7H97QZ
Molecule Type:
Small molecule
Molecular Formula:
C25H33ClN4O2S
Molecular Weight:
489.09
AlogP:
4.23
PSA:
62.04
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ABT-072
(2)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
ABT-072
×
Maximum Phase:
2
First Approval:
None
UNII:
PSQ4R5K1QI
Molecule Type:
Small molecule
Molecular Formula:
C24H27N3O5S
Molecular Weight:
469.56
AlogP:
3.37
PSA:
110.26
HBD:
2.0
HBA:
#RotB:
6.0
Source:
RAF-265
(2)
Small molecule
Serine/threonine-protein kinase B-raf inhibitor
Unknown
Investigational
Unknown
RAF-265
×
Maximum Phase:
2
First Approval:
None
UNII:
8O434L3768
Molecule Type:
Small molecule
Molecular Formula:
C24H16F6N6O
Molecular Weight:
518.42
AlogP:
6.93
PSA:
80.65
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PF-06459988
(2)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Investigational
Unknown
PF-06459988
×
Maximum Phase:
2
First Approval:
None
UNII:
5IE92SK9EB
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClN7O3
Molecular Weight:
431.88
AlogP:
2.13
PSA:
110.19
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CUDETAXESTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CUDETAXESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GTS-21
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GTS-21
×
Maximum Phase:
2
First Approval:
None
UNII:
8S399XDN2K
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O2
Molecular Weight:
308.38
AlogP:
3.77
PSA:
43.71
HBD:
0.0
HBA:
#RotB:
4.0
Source:
RISLENEMDAZ
(2)
Small molecule
Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
Unknown
Investigational
Unknown
RISLENEMDAZ
×
Maximum Phase:
2
First Approval:
None
UNII:
5HAM167S5T
Molecule Type:
Small molecule
Molecular Formula:
C19H23FN4O2
Molecular Weight:
358.42
AlogP:
3.19
PSA:
67.35
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TEZAMPANEL
(2)
Small molecule
Glutamate receptor ionotropic AMPA antagonist
Unknown
Investigational
Unknown
TEZAMPANEL
×
Maximum Phase:
2
First Approval:
None
UNII:
GA36S2O9C2
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O2
Molecular Weight:
279.34
AlogP:
0.61
PSA:
103.79
HBD:
3.0
HBA:
#RotB:
4.0
Source:
CGC-11047
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CGC-11047
×
Maximum Phase:
2
First Approval:
None
UNII:
2C4Y86R2AX
Molecule Type:
Small molecule
Molecular Formula:
C14H32N4
Molecular Weight:
256.44
AlogP:
0.72
PSA:
48.12
HBD:
4.0
HBA:
#RotB:
14.0
Source:
VOROLANIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VOROLANIB
×
Maximum Phase:
2
First Approval:
None
UNII:
YP8G3I74EL
Molecule Type:
Small molecule
Molecular Formula:
C23H26FN5O3
Molecular Weight:
439.49
AlogP:
2.75
PSA:
97.54
HBD:
3.0
HBA:
#RotB:
3.0
Source:
REZATOMIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
REZATOMIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
W5LMZ0RC8I
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2S
Molecular Weight:
232.35
AlogP:
3.84
PSA:
31.58
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GISADENAFIL
(2)
Small molecule
Phosphodiesterase 5A inhibitor
Unknown
Investigational
Unknown
GISADENAFIL
×
Maximum Phase:
2
First Approval:
None
UNII:
S6G4R7DI1C
Molecule Type:
Small molecule
Molecular Formula:
C23H33N7O5S
Molecular Weight:
519.63
AlogP:
1.12
PSA:
135.54
HBD:
1.0
HBA:
#RotB:
10.0
Source:
AV-101
(2)
Small molecule
Glutamate [NMDA] receptor antagonist
Unknown
Investigational
Unknown
AV-101
×
Maximum Phase:
2
First Approval:
None
UNII:
77XLH9L40B
Molecule Type:
Small molecule
Molecular Formula:
C10H11ClN2O3
Molecular Weight:
242.66
AlogP:
0.91
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
FISPEMIFENE
(2)
Small molecule
Estrogen receptor modulator
Unknown
Investigational
Unknown
FISPEMIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
3VZ2833V08
Molecule Type:
Small molecule
Molecular Formula:
C26H27ClO3
Molecular Weight:
422.95
AlogP:
5.66
PSA:
38.69
HBD:
1.0
HBA:
#RotB:
11.0
Source:
ORP-101
(2)
Small molecule
Kappa opioid receptor antagonist
Unknown
Investigational
Unknown
ORP-101
×
Maximum Phase:
2
First Approval:
None
UNII:
SE6KE496VO
Molecule Type:
Small molecule
Molecular Formula:
C60H84N2O8
Molecular Weight:
961.34
AlogP:
9.19
PSA:
102.32
HBD:
2.0
HBA:
#RotB:
13.0
Source:
RONICICLIB
(2)
Small molecule
Cyclin-dependent kinase inhibitor
Unknown
Investigational
Unknown
RONICICLIB
×
Maximum Phase:
2
First Approval:
None
UNII:
0W9Q8U337A
Molecule Type:
Small molecule
Molecular Formula:
C18H21F3N4O3S
Molecular Weight:
430.45
AlogP:
3.96
PSA:
108.19
HBD:
3.0
HBA:
#RotB:
7.0
Source:
GSK-2245035
(2)
Small molecule
Toll-like receptor 7 agonist
Unknown
Investigational
Unknown
GSK-2245035
×
Maximum Phase:
2
First Approval:
None
UNII:
5L3SX16QBQ
Molecule Type:
Small molecule
Molecular Formula:
C20H34N6O2
Molecular Weight:
390.53
AlogP:
2.93
PSA:
102.06
HBD:
2.0
HBA:
#RotB:
10.0
Source:
XL-281
(2)
Small molecule
Serine/threonine-protein kinase B-raf inhibitor
Unknown
Investigational
Unknown
XL-281
×
Maximum Phase:
2
First Approval:
None
UNII:
DW2NWI3TFN
Molecule Type:
Small molecule
Molecular Formula:
C24H19ClN4O4
Molecular Weight:
462.89
AlogP:
4.56
PSA:
107.55
HBD:
3.0
HBA:
#RotB:
3.0
Source:
FARGLITAZAR
(2)
Small molecule
Peroxisome proliferator-activated receptor gamma agonist
Unknown
Investigational
Unknown
FARGLITAZAR
×
Maximum Phase:
2
First Approval:
None
UNII:
3433GY7132
Molecule Type:
Small molecule
Molecular Formula:
C34H30N2O5
Molecular Weight:
546.62
AlogP:
6.61
PSA:
101.66
HBD:
2.0
HBA:
#RotB:
12.0
Source:
TILPISERTIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TILPISERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
A8Y5K4G762
Molecule Type:
Small molecule
Molecular Formula:
C33H33ClN8O
Molecular Weight:
593.13
AlogP:
6.37
PSA:
113.45
HBD:
2.0
HBA:
#RotB:
7.0
Source:
GALLIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GALLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
632XD903SP
Molecule Type:
Small molecule
Molecular Formula:
C7H6O5
Molecular Weight:
170.12
AlogP:
0.5
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
1.0
Source:
[18F]FLUOROMISONIDAZOLE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
[18F]FLUOROMISONIDAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
8MSY49469G
Molecule Type:
Small molecule
Molecular Formula:
C6H8FN3O3
Molecular Weight:
188.15
AlogP:
0.12
PSA:
81.19
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ODALASVIR
(2)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Investigational
Unknown
ODALASVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
OVR52K7BDW
Molecule Type:
Small molecule
Molecular Formula:
C60H72N8O6
Molecular Weight:
1001.29
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LB80380
(2)
Small molecule
DNA disrupting agent
Unknown
Investigational
Unknown
LB80380
×
Maximum Phase:
2
First Approval:
None
UNII:
S9I9P4J8IU
Molecule Type:
Small molecule
Molecular Formula:
C22H34N5O8P
Molecular Weight:
527.52
AlogP:
3.24
PSA:
166.98
HBD:
1.0
HBA:
#RotB:
11.0
Source:
SEPRANOLONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SEPRANOLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
3P8Z6V53MU
Molecule Type:
Small molecule
Molecular Formula:
C21H34O2
Molecular Weight:
318.5
AlogP:
4.6
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
NEZULCITINIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NEZULCITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
CXA4I8AH6A
Molecule Type:
Small molecule
Molecular Formula:
C30H37N7O2
Molecular Weight:
527.67
AlogP:
3.8
PSA:
104.38
HBD:
3.0
HBA:
#RotB:
6.0
Source:
GLYCERYL TRIOLEATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GLYCERYL TRIOLEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
O05EC62663
Molecule Type:
Small molecule
Molecular Formula:
C57H104O6
Molecular Weight:
885.45
AlogP:
18.1
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
50.0
Source:
VIPOGLANSTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VIPOGLANSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPETIRIMOD
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EPETIRIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
9P5MH9F521
Molecule Type:
Small molecule
Molecular Formula:
C13H15N5
Molecular Weight:
241.3
AlogP:
2.22
PSA:
69.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
INDANTADOL
(2)
Small molecule
Glutamate [NMDA] receptor antagonist
Unknown
Investigational
Unknown
INDANTADOL
×
Maximum Phase:
2
First Approval:
None
UNII:
Z3867B9SQP
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DARIGABAT
(2)
Small molecule
GABA-A receptor; anion channel agonist
Unknown
Investigational
Unknown
DARIGABAT
×
Maximum Phase:
2
First Approval:
None
UNII:
O9BP19HZ3Q
Molecule Type:
Small molecule
Molecular Formula:
C22H21FN4O3S
Molecular Weight:
440.5
AlogP:
4.12
PSA:
86.97
HBD:
0.0
HBA:
#RotB:
6.0
Source:
GRAPIPRANT
(2)
Small molecule
Prostanoid EP4 receptor antagonist
Unknown
Investigational
Unknown
GRAPIPRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
J9F5ZPH7NB
Molecule Type:
Small molecule
Molecular Formula:
C26H29N5O3S
Molecular Weight:
491.62
AlogP:
4.14
PSA:
105.98
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TEMPOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TEMPOL
×
Maximum Phase:
2
First Approval:
None
UNII:
U78ZX2F65X
Molecule Type:
Small molecule
Molecular Formula:
C9H18NO2
Molecular Weight:
172.25
AlogP:
1.35
PSA:
43.37
HBD:
1.0
HBA:
#RotB:
0.0
Source:
GUSACITINIB
(2)
Small molecule
Janus Kinase (JAK) inhibitor
Unknown
Investigational
Unknown
GUSACITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
4801QYW816
Molecule Type:
Small molecule
Molecular Formula:
C24H28N8O2
Molecular Weight:
460.54
AlogP:
2.55
PSA:
134.06
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LURTOTECAN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LURTOTECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
4J1L80T08I
Molecule Type:
Small molecule
Molecular Formula:
C28H30N4O6
Molecular Weight:
518.57
AlogP:
1.6
PSA:
106.36
HBD:
1.0
HBA:
#RotB:
3.0
Source:
1
2
…
143
144
145
146
147
148
149
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA